TERRY BARTMUS: Open Payments
NPI 1376966192 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 4 payments from 3 companies in 2025. Trend: 2023 $325 · 2024 $147 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $252 |
| Daiichi Sankyo Inc. | 1 | $135 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
Products named: INJECTAFER, Epclusa, FASENRA, Vemlidy.
Industry payments across NV — which companies pay providers there.
